Bruker Corporation $BRKR Shares Sold by Algert Global LLC

Key Points

• Algert Global LLC reduced its stake in Bruker Corporation by 21.2%, selling 23,638 shares, and now owns 87,760 shares valued at approximately $3.66 million.
• Multiple institutional investors, including London Co. of Virginia and Sculptor Capital LP, have significantly increased their holdings in Bruker, with the company currently having 79.52% of its stock owned by institutional investors.
• Bruker's recent earnings report showed an EPS of $0.32, slightly missing expectations, while analysts have mixed ratings with a consensus target price of $51.30.

Algert Global LLC trimmed its position in Bruker Corporation (NASDAQ:BRKR - Free Report) by 21.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 87,760 shares of the medical research company's stock after selling 23,638 shares during the period. Algert Global LLC owned approximately 0.06% of Bruker worth $3,663,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Teacher Retirement System of Texas grew its position in Bruker by 5.1% in the 1st quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock valued at $1,212,000 after buying an additional 1,422 shares during the last quarter. Fifth Third Bancorp grew its position in Bruker by 54.2% in the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after buying an additional 390 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Bruker by 81.2% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock valued at $1,245,000 after buying an additional 13,367 shares during the last quarter. OneDigital Investment Advisors LLC grew its holdings in Bruker by 38.0% during the first quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock worth $230,000 after acquiring an additional 1,520 shares during the period. Finally, UMB Bank n.a. raised its position in Bruker by 45.8% in the first quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company's stock worth $55,000 after acquiring an additional 416 shares in the last quarter. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Bruker

In related news, CEO Frank H. Laukien bought 2,608 shares of Bruker stock in a transaction that occurred on Friday, June 6th. The shares were purchased at an average price of $38.36 per share, with a total value of $100,042.88. Following the purchase, the chief executive officer owned 38,462,171 shares in the company, valued at $1,475,408,879.56. This represents a 0.01% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 27.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Bank of America cut their price objective on Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Wells Fargo & Company cut their price objective on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Barclays cut their price objective on Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Stifel Nicolaus set a $40.00 price objective on Bruker and gave the stock a "hold" rating in a research report on Tuesday, August 5th. Finally, The Goldman Sachs Group reduced their price objective on Bruker from $50.00 to $45.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $51.30.

Bruker Price Performance

BRKR stock traded up $1.74 during midday trading on Friday, hitting $35.54. 1,939,915 shares of the stock were exchanged, compared to its average volume of 3,459,438. Bruker Corporation has a fifty-two week low of $30.00 and a fifty-two week high of $72.94. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.70 and a current ratio of 1.61. The stock's 50-day moving average price is $38.48 and its 200-day moving average price is $41.05. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of 68.35, a PEG ratio of 2.79 and a beta of 1.16.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The company had revenue of $797.40 million during the quarter, compared to analysts' expectations of $811.17 million. During the same period in the previous year, the company posted $0.52 EPS. Bruker's quarterly revenue was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Research analysts predict that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 3rd. Investors of record on Tuesday, September 23rd will be paid a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, September 23rd. This represents a $0.20 dividend on an annualized basis and a yield of 0.6%. Bruker's dividend payout ratio is presently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.